Did chloroquine really fail a COVID-19 study—or was the trial design to blame?

26th March 2020 Uncategorised 0

News recently emerged that hydroxychloroquine—an anti-malaria drug highlighted by President Donald Trump as a promising coronavirus therapy—disappointed in a China clinical trial on mild COVID-19 patients. But a careful examination of the study reveals a more complicated situation.

More: Did chloroquine really fail a COVID-19 study—or was the trial design to blame?
Source: fierce